- Home
- BCAB vs GNSS Comparison
BCAB vs GNSS Comparison
Compare BCAB & GNSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCAB
- GNSS
- Stock Information
- Founded
- BCAB 2007
- GNSS 1992
- Country
- BCAB United States
- GNSS United States
- Employees
- BCAB N/A
- GNSS N/A
- Industry
- BCAB Medicinal Chemicals and Botanical Products
- GNSS Consumer Electronics/Appliances
- Sector
- BCAB Health Care
- GNSS Consumer Staples
- Exchange
- BCAB Nasdaq
- GNSS Nasdaq
- Market Cap
- BCAB 96.2M
- GNSS 169.5M
- IPO Year
- BCAB 2020
- GNSS N/A
- Fundamental
- Price
- BCAB $2.08
- GNSS $3.75
- Analyst Decision
- BCAB Strong Buy
- GNSS Strong Buy
- Analyst Count
- BCAB 2
- GNSS 3
- Target Price
- BCAB $6.00
- GNSS $5.08
- AVG Volume (30 Days)
- BCAB 1.6M
- GNSS 106.7K
- Earning Date
- BCAB 11-08-2024
- GNSS 12-05-2024
- Dividend Yield
- BCAB N/A
- GNSS N/A
- EPS Growth
- BCAB N/A
- GNSS N/A
- EPS
- BCAB N/A
- GNSS N/A
- Revenue
- BCAB N/A
- GNSS $27,968,000.00
- Revenue This Year
- BCAB N/A
- GNSS N/A
- Revenue Next Year
- BCAB N/A
- GNSS $138.10
- P/E Ratio
- BCAB N/A
- GNSS N/A
- Revenue Growth
- BCAB N/A
- GNSS N/A
- 52 Week Low
- BCAB $1.14
- GNSS $1.51
- 52 Week High
- BCAB $4.02
- GNSS $4.04
- Technical
- Relative Strength Index (RSI)
- BCAB 55.80
- GNSS 60.29
- Support Level
- BCAB $1.87
- GNSS $3.67
- Resistance Level
- BCAB $2.13
- GNSS $3.94
- Average True Range (ATR)
- BCAB 0.12
- GNSS 0.14
- MACD
- BCAB 0.00
- GNSS -0.02
- Stochastic Oscillator
- BCAB 68.90
- GNSS 77.78
About BCAB BioAtla Inc.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.
About GNSS Genasys Inc.
Genasys Inc is a provider of critical communications solutions designed to help keep people safe. The company is engaged in the design, development, and commercialization of directed and multidirectional sound technologies, voice broadcast products and location-based mass messaging solutions for emergency warning and workforce management. Its operating segment includes Hardware and Software. The company generates maximum revenue from the Hardware segment. Geographically, it derives a majority of revenue from the Americas region and also has its presence in the Asia Pacific and Europe, Middle East and Africa.